Werewolf Therapeutics Files Q1 2025 10-Q

Ticker: HOWL · Form: 10-Q · Filed: May 8, 2025 · CIK: 1785530

Werewolf Therapeutics, Inc. 10-Q Filing Summary
FieldDetail
CompanyWerewolf Therapeutics, Inc. (HOWL)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, financials

TL;DR

**Werewolf Therapeutics Q1 2025 10-Q filed. Financials updated.**

AI Summary

Werewolf Therapeutics, Inc. filed a 10-Q for the period ending March 31, 2025. The company is based in Watertown, MA, and operates in the pharmaceutical preparations sector. Key financial data points and stock information are included in the filing.

Why It Matters

This filing provides investors with an update on Werewolf Therapeutics' financial performance and position as of the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Werewolf Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
  • 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

  • Werewolf Therapeutics, Inc. (company) — Filer of the 10-Q
  • 200 Talcott Avenue, Watertown, MA 02472 (location) — Company business and mailing address
  • 2025-03-31 (date) — End of the reporting period
  • 2025-05-08 (date) — Date of filing

FAQ

What is the primary business of Werewolf Therapeutics, Inc.?

Werewolf Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.

What is the fiscal year end for Werewolf Therapeutics?

The fiscal year end for Werewolf Therapeutics is December 31st.

What is the SEC file number for Werewolf Therapeutics?

The SEC file number for Werewolf Therapeutics is 001-40366.

What is the reporting period covered by this 10-Q filing?

This 10-Q filing covers the period ending March 31, 2025.

Where is Werewolf Therapeutics, Inc. located?

Werewolf Therapeutics, Inc. is located at 200 Talcott Avenue, 2nd Floor, Watertown, MA 02472.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Werewolf Therapeutics, Inc. (HOWL).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.